66 related articles for article (PubMed ID: 35611804)
1. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
Sis B; Halloran PF
Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
[TBL] [Abstract][Full Text] [Related]
2. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
[TBL] [Abstract][Full Text] [Related]
3. Notch3 expression in capillary pericytes predicts worse graft outcome in human renal grafts with antibody-mediated rejection.
Xu-Dubois Y; Kavvadas P; Keuylian Z; Hertig A; Rondeau E; Chatziantoniou C
J Cell Mol Med; 2022 Jun; 26(11):3203-3212. PubMed ID: 35611804
[TBL] [Abstract][Full Text] [Related]
4. Markers of Endothelial-to-Mesenchymal Transition: Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients.
Xu-Dubois YC; Peltier J; Brocheriou I; Suberbielle-Boissel C; Djamali A; Reese S; Mooney N; Keuylian Z; Lion J; Ouali N; Levy PP; Jouanneau C; Rondeau E; Hertig A
J Am Soc Nephrol; 2016 Jan; 27(1):324-32. PubMed ID: 25995444
[TBL] [Abstract][Full Text] [Related]
5. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
[TBL] [Abstract][Full Text] [Related]
7. Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection.
Li X; Sun Q; Zhang M; Xie K; Chen J; Liu Z
J Immunol Res; 2014; 2014():582902. PubMed ID: 24741607
[TBL] [Abstract][Full Text] [Related]
8. Microvasculature partial endothelial mesenchymal transition in early posttransplant biopsy with acute tubular necrosis identifies poor recovery renal allografts.
Xu-Dubois YC; Ahmadpoor P; Brocheriou I; Louis K; Arzouk Snanoudj N; Rouvier P; Taupin JL; Corchia A; Galichon P; Barrou B; Giraud S; Hauet T; Jouanneau C; Rodenas A; Placier S; Niasse A; Ouchelouche S; Naimi BY; Akil E; Hertig A; Buob D; Rondeau E
Am J Transplant; 2020 Sep; 20(9):2400-2412. PubMed ID: 32167213
[TBL] [Abstract][Full Text] [Related]
9. Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss.
Louis K; Hertig A; Taupin JL; Buob D; Jamme M; Brocheriou I; Luque Y; Jouanneau C; Ouali N; Audouin M; Rondeau E; Xu-Dubois YC
Am J Transplant; 2019 Sep; 19(9):2434-2445. PubMed ID: 30836425
[TBL] [Abstract][Full Text] [Related]
10. The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts.
Haas M
Am J Transplant; 2018 Dec; 18(12):2849-2856. PubMed ID: 30133953
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Dysfunction in Kidney Transplantation.
Cardinal H; Dieudé M; Hébert MJ
Front Immunol; 2018; 9():1130. PubMed ID: 29875776
[TBL] [Abstract][Full Text] [Related]
12. Notch3 orchestrates epithelial and inflammatory responses to promote acute kidney injury.
Kavvadas P; Keuylian Z; Prakoura N; Placier S; Dorison A; Chadjichristos CE; Dussaule JC; Chatziantoniou C
Kidney Int; 2018 Jul; 94(1):126-138. PubMed ID: 29751972
[TBL] [Abstract][Full Text] [Related]
13. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
Haas M; Loupy A; Lefaucheur C; Roufosse C; Glotz D; Seron D; Nankivell BJ; Halloran PF; Colvin RB; Akalin E; Alachkar N; Bagnasco S; Bouatou Y; Becker JU; Cornell LD; Duong van Huyen JP; Gibson IW; Kraus ES; Mannon RB; Naesens M; Nickeleit V; Nickerson P; Segev DL; Singh HK; Stegall M; Randhawa P; Racusen L; Solez K; Mengel M
Am J Transplant; 2018 Feb; 18(2):293-307. PubMed ID: 29243394
[TBL] [Abstract][Full Text] [Related]
14. Loss of Notch3 Signaling in Vascular Smooth Muscle Cells Promotes Severe Heart Failure Upon Hypertension.
Ragot H; Monfort A; Baudet M; Azibani F; Fazal L; Merval R; Polidano E; Cohen-Solal A; Delcayre C; Vodovar N; Chatziantoniou C; Samuel JL
Hypertension; 2016 Aug; 68(2):392-400. PubMed ID: 27296994
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
